Tetanus Toxin

• USES: • For the temporary relief of symptoms including: • cough • fever • congestion These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.ICD-10: R05.9

DIRECTIONS: 1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age.

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, contact a physician or Poison Control Center right away. Tamper Evident: Sealed for your protection. Do not use if seal is broken or missing.

1. 1Abdominal Discomfort117%
2. 2Agitation117%
3. 3Arthralgia117%
4. 4Candida Infection117%
5. 5Cough117%
6. 6Cytopenia117%
7. 7Dacryostenosis Acquired117%
8. 8Dermatitis Diaper117%
9. 9Drug Ineffective117%
10. 10Dyspepsia117%
11. 11Exposure During Breast Feeding117%
12. 12Fatigue117%
13. 13Foetal Exposure During Pregnancy117%
14. 14Foetal Heart Rate Deceleration Abnormality117%
15. 15Headache117%

Recent PubMed references pinned to Tetanus Toxin as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

• Effect of long-term frozen storage on antibodies in blood samples: immunoglobulin, tetanus toxin antibody, and ABO antibody.
  Immunohematology · 2026 · Mikame M, Kitazaki H, Suzuki R, et al.
  PMID 41965232DOI 10.2478/immunohematology-2026-003
• Point-of-care detection of tetanus toxin based on a four-electrode dual-signal immunosensor with non-regenerative and synchronous tracking of co-biomarkers.
  Talanta · 2026 · Mo M, Li M, Li W, et al.
  PMID 41935515DOI 10.1016/j.talanta.2026.129711
• An ELISA-Based Alternative to Mouse Bioassays for Quantitative Evaluation of Tetanus Toxin.
  Toxins · 2026 · Shitada C, Sakamoto C, Kumeda K, et al.
  PMID 41893556DOI 10.3390/toxins18030133
• Clinical observations of tetanus toxin plus decoy, Snoretox-1, a novel targeted neuromuscular stimulant, in a pilot study of 6 British bulldogs with BOAS.
  Veterinary journal (London, England : 1997) · 2026 · Sasse A, Norbury LJ, McLean T, et al.
  PMID 41796891DOI 10.1016/j.tvjl.2026.106636
• A flexible antenna immunosensor with AuPt-graphene film for wireless detection of tetanus toxin.
  Analytica chimica acta · 2026 · Tian M, Xuan X, Liu C, et al.
  PMID 41791808DOI 10.1016/j.aca.2026.345259
• Gold/vertical-graphene-based dual-channel electrochemical immunosensor for point-of-care testing of tetanus toxin in blood.
  Biosensors & bioelectronics · 2026 · Zhang B, Li H, Li W, et al.
  PMID 41707428DOI 10.1016/j.bios.2026.118521
• Advances in Clostridial Neurotoxins: Passage of the Intestinal Barrier and Targeting of Specific Neuronal Cells.
  Toxins · 2026 · Popoff MR
  PMID 41591181DOI 10.3390/toxins18010035
• Synaptic Silencing with Transactivation of Tetanus Neurotoxin for Pathway-Selective Manipulation.
  Methods in molecular biology (Clifton, N.J.) · 2026 · Isa T, Isa K, Vanduffel W, et al.
  PMID 41273650DOI 10.1007/978-1-0716-4807-0_15

The 10 most recently updated of 48 ClinicalTrials.gov registrations naming Tetanus Toxin as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

• Clinical Trial of the 24-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid)
  Not yet recruiting · Phase 1 · Phase 2 · Interventional · 854 enrolled · CanSino Biologics Inc.
  NCT07600983updated 2026-05-22
• Exploratory Clinical Study of MT-2301
  Completed · Phase 2 · Interventional · 154 enrolled · Tanabe Pharma Corporation
  NCT02140047updated 2026-03-17
• The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial
  Completed · Phase 2 · Interventional · 41 enrolled · University of Minnesota
  NCT05650645updated 2026-02-10
• Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody Injection
  Enrolling by invitation · Phase 1 · Interventional · 68 enrolled · Lanzhou Institute of Biological Products Co., Ltd
  NCT07149454updated 2026-01-28
• Confirmatory Study of BK1310 in Healthy Infants
  Completed · Phase 3 · Interventional · 267 enrolled · Tanabe Pharma Corporation
  NCT03891758updated 2026-01-06
• Phase 3 Study of BK1310 in Healthy Infants
  Completed · Phase 3 · Interventional · 370 enrolled · Tanabe Pharma Corporation
  NCT02992925updated 2026-01-06
• Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Adults
  Active not recruiting · Phase 3 · Interventional · 2,399 enrolled · BioNet-Asia Co., Ltd.
  NCT06798831updated 2025-10-03
• Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants
  Completed · Phase 2 · Interventional · 852 enrolled · Sanofi Pasteur, a Sanofi Company
  NCT04398706updated 2025-09-08
• Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance
  Recruiting · Observational · 56 enrolled · Fondazione Italiana Linfomi - ETS
  NCT06070961updated 2025-06-29
• Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Fully Human Anti-tetanus Toxin Monoclonal Antibody A82 / B86 Injection Combination Formulation
  Unknown · Early phase 1 · Interventional · 190 enrolled · Changchun BCHT Biotechnology Co.
  NCT06360250updated 2024-04-11

Frequently asked questions

What is Tetanus Toxin used for?

According to FDA labeling, Tetanus Toxin carries indications including: USES: • For the temporary relief of symptoms including: • cough • fever • congestion These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.